Claritas Pharmaceuticals Share Price Toronto S.E.
Equities
KLY
CA1806341071
Biotechnology & Medical Research
Sales 2019 | - | Sales 2020 | - | Capitalization | 13.65M 18.68M 1.09B |
---|---|---|---|---|---|
Net income 2019 | -21M -28.74M -1.67B | Net income 2020 | 4M 5.47M 319M | EV / Sales 2019 | - |
Net Debt 2019 | 704K 963K 56.12M | Net Debt 2020 | 920K 1.26M 73.34M | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |